The androgen receptor and DXS15-134 markers show a high rate of discordance for germline X chromosome inactivation [6]

Journal of Medical Genetics

Volumn 38, Issue 7, 2001, Pages 474-478

  Mahavni, V ^a   Kim, S C ^a   Benda, T A ^a   Sanders, L ^a   Buller, R E ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER;

BREAST CANCER; CHROMOSOME 10Q; CHROMOSOME MAP; CHROMOSOME MARKER; DIAGNOSTIC VALUE; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE LOCUS; GERM LINE; HUMAN; LETTER; MAJOR CLINICAL STUDY; OVARY CANCER; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION; X CHROMOSOME LINKED DISORDER;

ALLELES; BREAST NEOPLASMS; COHORT STUDIES; DOSAGE COMPENSATION, GENETIC; FEMALE; GENE DOSAGE; GENETIC MARKERS; GENOTYPE; GERM-LINE MUTATION; HUMANS; JAPAN; OVARIAN NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0034933736     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (25)

1. Allocycly of the X chromosome in rumors and normal tissue
2. Gene action in the X chromosome of the mouse (Mus musculus L)
3. X inactivation in females with X-linked disease
4. Association between nonrandom X-chromosome inactivation and BRCA 1 mutation in germline DNA of patients with ovarian cancer
5. Mutation and cancer: Statistical study of retinoblastoma
6. Hormone and smoking related cancers further define a role for nonrandom X-chromosome inactivation in carcinogenesis
7. Clonal analysis of hematopoietic cells using a novel polymorphic site of the X chromosome
8. Absence of significant germline p53 mutations in ovarian cancer patients
9. p53 allelotypes and enhanced detection of allelic loss on ovarian cancer: Lack of correlation with familial and clinical factors
10. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers
11. PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies
12. Long range cis effects of ectopic X-inactivation centres on a mouse autosome
13. X Chromosome inactivation and the XIST gene
14. Role of the Xist gene in X chromosome choosing
15. The human XIST gene; analysis of a 17 kb inactive X specific RNA that contains conserved repeats and is highly conserved within the nucleus
16. Xist has properties of the X- chromosome inactivation centre
17. Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: The Lyon repeat hypothesis
18. Expression of genes from the human active and inactive X chromosome
19. Role of the X chromosome in cancer
20. X-chromosome inactivation and the Xg locus
21. X chromosome inactivation patterns using HPRT and PGK polymorphisms in haematologically normal and post-chemotherapy females
22. Clonal analysis using recombinant DNA probes from the X-chromosome
23. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X chromosome inactivation
24. Genetic variation at five trimeric and tetrameric repeat loci in four human population groups
25. Clonality analysis in tumours of women by PCR amplification of X-linked genes